Provided by Tiger Trade Technology Pte. Ltd.

Guardant Health Inc.

178.36
+0.63000.35%
Pre-market: 179.501.14+0.64%05:17 EDT
Volume:1.58M
Turnover:282.70M
Market Cap:23.94B
PE:-50.91
High:180.34
Open:177.75
Low:175.33
Close:177.73
52wk High:183.51
52wk Low:60.45
Shares:134.20M
Float Shares:129.78M
Volume Ratio:0.92
T/O Rate:1.22%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-3.5037
EPS(LYR):-3.3203
ROE:-4584.47%
ROA:-18.07%
PB:-107.40
PE(LYR):-53.72

Loading ...

Guardant Health Chief Commercial Officer Chris Freeman Disposes of $ 10.75 Million in Common Shares

Reuters
·
Aug 12

Guardant Health Grants 46,044 RSUs to 149 New Employees Under Inducement Plan

Reuters
·
Aug 11

Is GH Research’s Rising Loss Per Share Reframing the GHRS Cash Burn Narrative?

Simply Wall St.
·
Aug 10

Guardant Health (GH) Following Earnings And Higher Guidance Has Valuation Back In Focus

Simply Wall St.
·
Aug 08

RBC Capital Remains a Buy on GH Research (GHRS)

TIPRANKS
·
Aug 08

Analysts Have Conflicting Sentiments on These Healthcare Companies: InMode (INMD), GH Research (GHRS) and Scholar Rock Holding (SRRK)

TIPRANKS
·
Aug 08

Movement Alert|Guardant Health Inc. Rises 5.39% in Regular Trading, Q2 Revenue Beat and Full-Year Guidance Raise Extend Post-Earnings Momentum

Market Focus
·
Aug 07

GH Research is Maintained at Buy by Needham

Dow Jones
·
Aug 07

GH Research price target raised to $39 from $32 at Needham

TIPRANKS
·
Aug 07

GH Research reports Q2 EPS (23c), consensus (30c)

TIPRANKS
·
Aug 06

GH Research Q2 EPS $(0.23) Beats $(0.30) Estimate

Benzinga Earnings
·
Aug 06

Guardant Health Director Ian T. Clark Disposes of Common Shares Worth $2.25 Million

Reuters
·
Aug 06

Guardant Health is Maintained at Overweight by Morgan Stanley

Dow Jones
·
Aug 04

Guardant Health (GH) Filed A Shelf Registration To Keep Future Funding Options Open

Simply Wall St.
·
Aug 04

Analysts Conflicted on These Healthcare Names: Guardant Health (GH) and Cardinal Health (CAH)

TIPRANKS
·
Aug 03

Guardant Health Shares Climb Following Outlook Raise

Dow Jones
·
Jul 31

Movement Alert|Guardant Health Inc. Rises 10.72% in Regular Trading, Q2 Revenue Significantly Beats Expectations with Full-Year Guidance Raised

Market Focus
·
Jul 31

RBC Raises Price Target on Guardant Health to $200 From $185, Keeps Outperform Rating

MT Newswires Live
·
Jul 31

Guardant Health is Maintained at Buy by BTIG

Dow Jones
·
Jul 31

Guardant Health Inc Reports Results for the Quarter Ended June 30 - Earnings Summary

Reuters
·
Jul 31